Cannon Kara 4
4 · ENZO BIOCHEM INC · Filed Mar 28, 2022
Insider Transaction Report
Form 4
Cannon Kara
DirectorChief Executive Officer
Transactions
- Award
Stock Option (to acquire Common Stock)
2022-03-24+87,500→ 87,500 totalExercise: $2.98From: 2023-03-24Exp: 2027-03-24→ Common Stock (87,500 underlying)
Holdings
- 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.20From: 2021-02-24Exp: 2025-02-24→ Common Stock (55,400 underlying) - 52,000
Stock Option (to acquire Common Stock)
Exercise: $2.80From: 2020-01-03Exp: 2024-01-03→ Common Stock (52,000 underlying) - 87,500
Stock Option (to acquire Common Stock)
Exercise: $3.36From: 2023-02-11Exp: 2027-02-11→ Common Stock (87,500 underlying) - 22,614(indirect: By 401(k))
Common Stock, $0.01 Par Value
- 55,400
Stock Option (to acquire Common Stock)
Exercise: $2.63From: 2022-01-11Exp: 2026-01-11→ Common Stock (55,400 underlying) - 35,000
Stock Option (to acquire Common Stock)
Exercise: $4.42From: 2019-07-31Exp: 2023-07-30→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.